urea has been researched along with mk 0663 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Best, AE; Duan, WR; Faltynek, CR; Locke, C; Nothaft, W; Othman, AA; Reeh, P; Schaffler, K | 1 |
| Abel, AK; Becker, ML; Brigham, NC; Dreger, NZ; Forster, SP; Gustafson, TP; Hermans, A; Ji, RR; Luo, X; Nofsinger, R | 1 |
1 trial(s) available for urea and mk 0663
| Article | Year |
|---|---|
An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Evoked Potentials; Hot Temperature; Humans; Indazoles; Lasers, Gas; Male; Pain; Pain Measurement; Pyridines; Severity of Illness Index; Skin; Sulfones; Tramadol; TRPV Cation Channels; Ultraviolet Rays; Urea | 2013 |
1 other study(ies) available for urea and mk 0663
| Article | Year |
|---|---|
Controlled release of etoricoxib from poly(ester urea) films for post-operative pain management.
Topics: Animals; Cyclooxygenase 2 Inhibitors; Delayed-Action Preparations; Double-Blind Method; Esters; Etoricoxib; Humans; Mice; Pain, Postoperative; Pyridines; Rats; Sulfones; Urea | 2021 |